Literature DB >> 6329889

Cyclic nucleotides and glycoproteins during formation of cholesterol gallstones in prairie dogs.

R A Zak, P G Frenkiel, J W Marks, G G Bonorris, A Allen, L J Schoenfield.   

Abstract

Male prairie dogs received in standard diets either 0.08% cholesterol (control, n = 30) or 1.2% cholesterol (lithogenic, n = 31). Animals were killed at days 2-4, 7, 10, 21, and 39 to determine the temporal sequence of changes in mucosal cyclic adenosine 3':5'-monophosphate in the gallbladder and of cholesterol saturation, glycoproteins, cholesterol crystals, and gallstones in bile of prairie dogs fed a cholesterol-rich lithogenic diet. Glycoprotein concentration in bile in the lithogenic group was significantly elevated compared to controls on all days of death. Saturation of bile and formation of cholesterol crystals occurred only in the lithogenic group, detected first after 7 days of feeding. Gallstones were found in the lithogenic group only. Elevation of cyclic adenosine 3':5'-monophosphate in the mucosa of gallbladders was found in the lithogenic group only, beginning at day 10. In summary, increased glycoproteins in bile preceded cholesterol saturation and crystallization which, in turn, preceded increased mucosal cyclic adenosine 3':5'-monophosphate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329889

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.

Authors:  S Sahlin; J Ahlberg; K Einarsson; R Henriksson; A Danielsson
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 2.  On the mechanical behavior of the human biliary system.

Authors:  Xiaoyu Luo; Wenguang Li; Nigel Bird; Swee Boon Chin; N A Hill; Alan G Johnson
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

3.  Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.

Authors:  S Sahlin; A Danielsson; B Angelin; E Reihnér; R Henriksson; K Einarsson
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.